SUMMARY Thyroid function was assessed in three selected groups of children who had survived cancer. Children in group 1 had received radiotherapy to the thyroid area, group 2 had radiotherapy to the thyroid area and adjuvant chemotherapy, and group 3 had chemotherapy with or without radiotherapy away from the thyroid area. There were 75 survivors and 63 (40 boys, 23 girls) were available for study. Eighteen (29%) were found to have thyroid dysfunction, and these included all those who had had lymphangiograms or received a radiation dose greater than 40 Gy to the thyroid area. Only nine of the 18 children were already known to have thyroid dysfunction, and only 15 of 44 children who had had irradiation to the thyroid area had had their thyroid function examined.
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This study shows that children who have received radiotherapy to the thyroid area should have their thyroid function assessed regularly. Chemotherapy does not appear to be a risk factor but longer follow up of these children is necessary.
The survival rates for childhood cancer (B) Hodgkin's disease patients (n=13) Five patients had chemotherapy alone or chemotherapy plus radiotherapy away from the thyroid area and all but one had normal thyroid function; the exception was a child who had a diagnostic lymphangiogram. Four patients had chemotherapy plus mediastinal irradiation of 35 Gy and one had thyroid dysfunction. Four patients had radiotherapy in excess of 24 Gy (mean 35 Gy) involving the thyroid area and all had thyroid dysfunction. A total of four patients had lymphangiograms (three also had radiotherapy in excess of 38 Gy to the thyroid area) and all have developed hypothyroidism.
(C) Leukaemia patients Acute myeloid leukaemia (n=6)-Three patients had chemotherapy alone and all had normal thyroid function. Two patients had chemotherapy plus total body irradiation (a mean dose of 10-7 Gy in one fraction) and one of them had thyroid dysfunction. The sixth patient had spinal irradiation (12 fraction of 2 Gy in 30 days) and he had thyroid dysfunction.
Acute lymphoblastic leukaemia (n=8)-All received radiotherapy involving the thyroid area in 12 fractions during brain or whole central nervous system irradiation for meningeal disease. Only two had thyroid dysfunction having received 23 and 30 Gy to the thyroid respectively. The remaining six patients' radiotherapy dose was 10-18-1 Gy.
(D) Rhabdomyosarcoma patients (n=9) Five patients received radiotherapy involving the thyroid gland . Three who received 50-56 Gy became hypothyroid; the other two patients received 20 Gy to the thyroid area and both had normal thyroid function. Four patients received radiotherapy away from the thyroid gland and they had normal thyroid function.
(E) Bone tumours (n=10) All had received intensive chemotherapy alone or in combination with radiotherapy not involving the thyroid gland area. All had normal thyroid function.
(F) Cerebral tumours (n=3) All had received intensive chemotherapy and a Thyroid function in survivors of cancer 711 very small dose of irradiation to the thyroid area (40-240 cGy). All had normal thyroid function.
Discussion
The improved survival of children with neoplastic disease has been accompanied by an increase in the side effects of treatment and this includes endocrine disease.2 3 7 8 In particular children who have had external beam irradiation to the neck may become hypothyroid3 9 and develop thyroid neoplasms. 6 Although the thyroid gland is relatively radioresistant, its sensitivity is influenced by mitotic activity so that the gland is more vulnerable during its growth in childhood. 10 We have found a prevalence of thyroid dysfunction after external irradiation to the neck of 40%; other reports vary from 16.511 to 97%.10 These wide differences reflect variables such as dose of irradiation, age of the patient, length of follow up, and possibly the sensitivity of the laboratory tests. Some authors have made a distinction between compensated and true hypothyroidism,12 13 and they report the prevalence of compensated hypothyroidism to be between 29-44%.1 14 Our figure of 25% is similar in this respect. The mechanism by which hypothyroidism develops after irradiation to the neck-whether due to vascular damage, impairment of regeneration, or immunologic reaction-is not clear.15 Rubin and Casarrett suggested that thyroid irradiation damages both capillaries and endothelium, and that with small doses regeneration takes place. 16 They suggested that with larger doses, however, the residual vascular damage is responsible for a second phase ofdegeneration of the follicular epithelium and subsequent decrease of thyroid function. In our series the dose of irradiation was important and all those who had had an irradiation dose to the thyroid gland of 40 Gy have developed thyroid dysfunction.
The association between lymphangiography and an increased incidence of hypothyroidism has been documented a number of times.14 17 The fat soluble organic iodide used in the lymphangiogram remains in the body for several months, and with its slow and continuous release from lymph nodes it leads to chronic iodide load to the thyroid gland (Wolff- 22 and it is possible that a damaged gland continuously stimulated by raised concentrations of thyroid stimulating hormone may be at a greater risk of adenomatous and carcinomatous changes.
We believe that all patients who have received irradiation to the neck should have their thyroid function assessed annually for an indeterminate period, and that those with persistently raised thyroid stimulating hormone concentrations (which may rise transiently immediately after irradiation to the neck) should receive thyroid hormone replacement. As the peak incidence of thyroid carcinoma occurs 20 to 30 years after radiation exposure22 indefinite follow up is essential and palpation of the thyroid gland included at every examination.
Our study and others suggest that the&'thyroid gland appears to be relatively immune to the common cytotoxic agents used for cancer treatment, but this can only be clarified by long term studies.
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